Navigation Links
Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Date:10/27/2008

tivitis to grass pollens.

It contains a mix of five standardized grass pollens, mimicking patients' natural exposure: perennial rye grass (Lolium perenne), meadow grass (Poa pratensis), timothy grass (Phleum pratense), cocksfoot (Dactylis glomerata) and sweet vernal grass (Anthoxanthum odoratum).

Oralair(R) Grasses has been shown to be effective in rhinoconjunctivitis caused by allergy to grass pollens from the first season, throughout the entire pollen season and during pollen peaks:

- in poly- and mono-sensitized patients and asthmatic patients,

- on every individual symptom, and, in particular, on nasal congestion and watery eyes.

Oralair(R) Grasses is indicated as a pre- and co-seasonal treatment: treatment should be started four months before the pollen season starts and then be maintained throughout the season. Treatment should be repeated, following the same protocol, for 3 consecutive pollen seasons.

About Quintiles

Quintiles Transnational Corp. fuels the new generation of medical care by providing a broad range of professional services in drug development, financial partnership, and marketing for the pharmaceuticals, biotechnology, and medical care industries. With over 21,000 employees, and offices in over 50 countries, it is focused on providing customer-centered solutions that constitute the reference standard for the industry.

For further information, please consult the Web Site of the Company at http://www.quintiles.com.

About Stallergenes

Stallergenes is a European biopharmaceutical company dedicated to desensitization therapies for the prevention and treatment of allergy-related respiratory diseases, e.g. rhinoconjunctivitis and allergic asthma. A pioneer and leader in sublingual desensitization treatments, Stallergenes devotes 20% of its turnover in raw data to Research and Development and is actively involved in the development
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
2. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
3. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
4. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
5. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
6. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
7. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
8. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
9. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
10. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
11. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wire-FirstCall/--NeogenCorporation(Nasdaq: NEOG )a...toNeogen,sBoardofDirectorsatthecompany,srecentannu...0yearsofexperienceinthefood,agriculture,andtradein...riculturaleconomicsatVirginiaTechUniversity.FromJa...griculturenegotiatorwiththerankofambassador. ,,...
(Date:11/23/2009)...RNewswire/--PearlTherapeuticsInc.,abiopharmaceutic...entofchronicrespiratorydiseases,todayannouncedthea...rs.Mr.Rosenhas25yearsofexperienceinthepharmaceutic...leadSciencesandALZACorporation.Hisappointmentincre... "Howiebringsawealthofproductdevelopment,commercia...
(Date:11/20/2009)...swire-FirstCall/ -- Dendreon Corporation (Nasdaq: ...g Administration (FDA) provided written acknowledg... Application (BLA) for PROVENGE® (sipuleucel-... Prescription Drug User Fee Act (PDUFA) date of Ma...on,s amended BLA. Dendreon is seeking licensure f...
(Date:11/20/2009)...OLEDO recently announced that Dr. Dominique Hebrau... Process Analytical Technology (PAT) in Green Chem...2009. , (PRWEB) November ...ical Technology (PAT) in Green Chemistry and Green...tical Technology (PAT) case studies will be presen...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...covery , a stem cell business launched late last y...receive $1 million in state funding, and more help...nts. , ,The funding comes in the form of a $500,00.... Stemina Biomarker will use the loan to purchase ...e rest of the funding for other equipment, to buil...
...ident of the health services division of Siemens ...ical technology companies. She has something in co...f Wisconsin Hospitals and Clinics - both recently...y Modern Healthcare magazine. , , Below are som...ne. , , WTN: With respect to medical inf...
...tired CIO of Meriter Hospital , believes healthca...ncreases costs. , ,Why that distortion exists cou...occupied a fair amount of time during Digital Hea... with the Joneses, and have the latest in health i...alth IT costs. As the industry moves toward greate...
Other Biology Technology:Madison stem cell company gets $1M from state 2Madison stem cell company gets $1M from state 3Madison stem cell company gets $1M from state 4Siemens health services president calls IT benefits unassailable 2Siemens health services president calls IT benefits unassailable 3Siemens health services president calls IT benefits unassailable 4Siemens health services president calls IT benefits unassailable 5DHC 2007: Controlling health IT costs the key to capturing value 2DHC 2007: Controlling health IT costs the key to capturing value 3DHC 2007: Controlling health IT costs the key to capturing value 4
(Date:11/23/2009)... that a common oral bacterium may exacerbate autoi...l, "Unique Lipids from a Common Human Bacterium Re...ancing Autoimmunity," appears in the December 2009... Multiple sclerosis (MS), a disease where the immu...ts nearly 1 in 700 people in the United States. P...
(Date:11/23/2009)...ersity of Alabama at Birmingham (UAB) researchers ...edical conditions (co-morbidity) do not explain th...ans compared to Caucasians who also have colon can...cer , a journal of the American Cancer Society. ,...orbidity are independent predictors of poor surviv...
(Date:11/23/2009)...ted for 360 million years and survived when the di...ening to make many of them extinct, according to a...oday . , The fungus, Batrachochytrium dendroba... of amphibian extinctions in Central America and n...ver 350 amphibian species by penetrating their ski...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Wildlife Conservation Society to expand health surveillance through PREDICT 10501 1Wildlife Conservation Society to expand health surveillance through PREDICT 10501 2Wildlife Conservation Society to expand health surveillance through PREDICT 10501 3Bladder Problems May Often Be Related to Mental Health 59989 1Bladder Problems May Often Be Related to Mental Health 59989 2Learning the risks for stroke and taking action 59987 1Learning the risks for stroke and taking action 59987 2Learning the risks for stroke and taking action 59987 3
...erging Nanotechnologies Director David Rejeski, “T...sponsibilities for nanotechnology oversight. If na...as scored the first run in the first inning. But t...ement the Nanotechnology Task Force’s recommendati...commendations in the Task Force report, FDA will n...
... the cell know to send the signal that announces a...ng good sensations, the answer appears to be sugar...pearing with a commentary in Nature Neuroscience o...opens a gate in the cell membrane and brings news ...ymond Stevens of The Scripps Research Institute, w...
...erited gene mutation that increases a person,s ris...he most common forms of the disease. , The study ...the gene,s protective activity. Furthermore, a sec...e off altogether, leading to leukemia. This latter...ited. , The findings could help identify peopl...
Other Biology News:FDA sees nanotech challenges in every product category it regulates 2Nicotine rush hinges on sugar in neurons 2Researchers discover inherited mutation for leukemia 2Researchers discover inherited mutation for leukemia 3
... at its Best: DASGIPs Process Control integrates P...Changes & comprehensive documentation for cultivat...pH, dissolved oxygen, temperature and agitation sp..., e.g. constant or scheduled media flow, are chan...
...vides a genome-wide microRNA (miRNA) expression pr...ietary probe design, which enable highly sensitive... have standard arrays for mature miRNA of all spec...miRBase database (Release 8.2). Our service is com...
...8 amino acid synthetic peptide whose sequences are...e of this peptide is (amino to carboxy terminus): ...- D - K - K - I - K - Q - D - C(39). This peptid...iments with the polyclonal antibody that reacts wi...
...oteomic Imaging System, Basic Package Superior Pr...ic Range: The ProXPRESS 2D Proteomic Imaging Syste... proteomic and general life science research appli...ility, enabling the use of all dyes in the UV and ...
Biology Products: